Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Progesterone vaginal tablets for recurrent pregnancy loss
jRCTs041260094Recruiting
- Sponsor
- Grants-in-Aid for Scientific Research
- Start
- Sep 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of progesterone in recurrent miscarriage (RPL), sponsored by Grants-in-Aid for Scientific Research. Primary endpoint: Live birth rate at or after 24 weeks of gestation. Started Sep 2026; status: recruiting.
02
Drugs
progesterone
03
Conditions
recurrent miscarriage (RPL)
Beyond the preview
Go deeper on jRCTs041260094.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041260094.